Search for other papers by Simon H.S. Pearce in
Google Scholar
PubMed
Search for other papers by Mario Vaisman in
Google Scholar
PubMed
Search for other papers by Jean-Louis Wemeau in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is defined by an elevation of the serum TSH with circulating free thyroid hormone concentrations that are within the reference range [ 1 ]. It is a common issue in clinical practice that
Royal Victoria Infirmary, Newcastle upon Tyne, UK
Search for other papers by Simon H.S. Pearce in
Google Scholar
PubMed
Search for other papers by Georg Brabant in
Google Scholar
PubMed
Search for other papers by Leonidas H. Duntas in
Google Scholar
PubMed
Search for other papers by Fabio Monzani in
Google Scholar
PubMed
Search for other papers by Robin P. Peeters in
Google Scholar
PubMed
Queen Elizabeth Hospital, Gateshead, UK
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Jean-Louis Wemeau in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is defined as a state of increased serum thyroid-stimulating hormone (TSH) levels, with circulating thyroxine (T 4 ) and tri-iodothyronine (T 3 ) concentrations within the population reference
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Roberto Attanasio in
Google Scholar
PubMed
Search for other papers by Enrico Papini in
Google Scholar
PubMed
Search for other papers by Rinaldo Guglielmi in
Google Scholar
PubMed
Search for other papers by Franco Grimaldi in
Google Scholar
PubMed
Search for other papers by Vincenzo Toscano in
Google Scholar
PubMed
Search for other papers by Dan Alexandru Niculescu in
Google Scholar
PubMed
Search for other papers by Diana Loreta Paun in
Google Scholar
PubMed
Search for other papers by Catalina Poiana in
Google Scholar
PubMed
in childbearing age, and the evidence of adverse events especially associated with overt thyroid disease. Among thyroid diseases, thyroid autoimmunity (TAI) and subclinical hypothyroidism (SCH) are by far the most frequent, involving at least 10% of
Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by Jesper Karmisholt in
Google Scholar
PubMed
Clinical Institute, Aalborg University, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is a frequent condition defined by serum values of thyrotropin (TSH) above and thyroxine (T4) within the population-based reference ranges[ 1 - 3 ]. It may reflect mild thyroid failure with only
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Bronia Arnott in
Google Scholar
PubMed
Search for other papers by Dawn Teare in
Google Scholar
PubMed
Search for other papers by Shaun Hiu in
Google Scholar
PubMed
Search for other papers by Nicki O’Brien in
Google Scholar
PubMed
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) is a mild form of thyroid failure diagnosed when serum TSH levels are high and circulating thyroid hormones are within the reference range [ 1 , 2 ]. The prevalence of SCH increases with age and
Search for other papers by John Lazarus in
Google Scholar
PubMed
Search for other papers by Rosalind S. Brown in
Google Scholar
PubMed
Search for other papers by Chantal Daumerie in
Google Scholar
PubMed
Search for other papers by Alicja Hubalewska-Dydejczyk in
Google Scholar
PubMed
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Bijay Vaidya in
Google Scholar
PubMed
Introduction Subclinical hypothyroidism (SCH) in pregnancy is defined by a serum thyroid-stimulating hormone (TSH) concentration higher than the upper limit of the pregnancy-related reference range associated with a normal serum thyroxine [T 4
Search for other papers by Nadine Johnson in
Google Scholar
PubMed
Search for other papers by Vikash Chatrani in
Google Scholar
PubMed
Search for other papers by Anna-Kay Taylor-Christmas in
Google Scholar
PubMed
Search for other papers by Eric Choo-Kang in
Google Scholar
PubMed
Search for other papers by Monica Smikle in
Google Scholar
PubMed
Search for other papers by Rosemarie Wright-Pascoe in
Google Scholar
PubMed
Search for other papers by Karen Phillips in
Google Scholar
PubMed
Search for other papers by Marvin Reid in
Google Scholar
PubMed
Introduction Hypothyroidism is the most common disorder of thyroid function in pregnancy [ 1 ]. Subclinical hypothyroidism (SCH) is defined as serum thyroid-stimulating hormone (TSH) >97.5% and normal free thyroxine (FT 4 ), with or without
Search for other papers by Horea Ioan Ursu in
Google Scholar
PubMed
Dear Sir, In my view, an additional treatment indication for subclinical hypothyroidism (table 2 in Pearce et al. [ 1 ]) might be represented by patients with melanomas, the most aggressive malignancy arising from the skin. This suggestion
Search for other papers by Wilmar M. Wiersinga in
Google Scholar
PubMed
The ETA guidelines on subclinical hyperthyroidism (SHyper) in the present issue of European Thyroid Journal [ 1 ], together with the previously published ETA guidelines on subclinical hypothyroidism (SHypo) [ 2 , 3 ], offer up
Search for other papers by David J. Stott in
Google Scholar
PubMed
Search for other papers by Douglas C. Bauer in
Google Scholar
PubMed
Search for other papers by Ian Ford in
Google Scholar
PubMed
Search for other papers by Patricia Kearney in
Google Scholar
PubMed
Search for other papers by Jacobijn Gussekloo in
Google Scholar
PubMed
Search for other papers by Terence J. Quinn in
Google Scholar
PubMed
Search for other papers by Nicolas Rodondi in
Google Scholar
PubMed
Search for other papers by Jan Smit in
Google Scholar
PubMed
Search for other papers by Rudi Westerdorp in
Google Scholar
PubMed
Dear Editor, The recent European Thyroid Association (ETA) guideline on the treatment of subclinical hypothyroidism (SCH) [ 1 ] will potentially be widely used by clinicians faced with this common condition. Although the report includes much